Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Wuxi Zhikang Hongyi Biotechnology

Request full access

Innovative oncology solutions with advanced WEE1 inhibitors for late-stage ovarian cancer treatment

ChinaFounded 2017Robotics

About Wuxi Zhikang Hongyi Biotechnology

BioCity Pharma specializes in developing cutting-edge oncology treatments, focusing on late-stage ovarian cancer. The company operates in the biopharmaceutical market, targeting healthcare providers and research institutions. Its business model revolves around the research, development, and commercialization of novel cancer therapies, particularly WEE1 small molecular inhibitors like SC0191. Revenue is generated through clinical trials, partnerships with pharmaceutical companies, and eventual drug sales upon regulatory approval. BioCity Pharma's recent achievement includes obtaining implicit authorization from the National Drug Supervisory Authority (NMPA) for SC0191, which will be used in conjunction with chemotherapy drugs for advanced ovarian cancer. This marks the third clinical permit for the SC0191 project, with the company poised to commence Ib II phase clinical research soon.

Source: Dealroom company data

At a glance

Status
Operational
Employees
10
Open positions
None listed
Dealroom signal
43.4/100
Industry
Robotics
Sector
DT and LS, science-based
Technology
Deep Tech
Business model
Manufacturing
Client focus
B2B

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Aug 2024 $28M $110M Wuxi Innovation Investment Group · Binhu Industrial Group · WuXi Biologics ↗
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Wuxi Zhikang Hongyi Biotechnology website traffic

Latest recorded traffic for Wuxi Zhikang Hongyi Biotechnology is 970 monthly website visits, up 40.6% over the last three months. Wuxi Zhikang Hongyi Biotechnology's team grew 42.9% over the past year.

Latest monthly visits970 3-month web change+40.6% 1-year team growth+42.9%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Wuxi Zhikang Hongyi Biotechnology in its local ecosystem

Live from Dealroom

The Wuxi Zhikang Hongyi Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

  • Wuxi Innovation Investment Group
  • Binhu Industrial Group
  • WuXi Biologics
Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇨🇳 China50%
🇺🇸 United States50%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Wuxi Zhikang Hongyi Biotechnology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Wuxi Zhikang Hongyi Biotechnology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.